LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹33 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr | ₹39 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹33 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹43 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹39 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | -4.09 | |
Mar2023 | ₹34 Cr | -20.24 | |
Mar2022 | ₹43 Cr | 3.93 | |
Mar2021 | ₹41 Cr | 4.66 | |
Mar2020 | ₹39 Cr | - |
Compare Contingent Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹421.1 Cr | 2.2% | 5.6% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,358.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,957.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,197.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 2.2% |
5.6% |
9.8% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses